THOMAS ORTEL, M.D.
Osteopathic Medicine at Erwin Rd, Durham, NC
License number
North Carolina 37916
Category
Osteopathic Medicine
Type
Hematology
Address
Address
Erwin Rd, Durham, NC 27710
Phone
(919) 620-4467
(919) 684-8111
(919) 684-8111
Organization information
See more information about THOMAS ORTEL at bizstanding.comThomas Ortel MD,PHD
2100 Erwin Rd, Durham, NC 27705
Industry:
Internist
Phone:
(919) 620-4467 (Phone)
Thomas Lee Ortel
Professional information
Dr. Thomas Ortel, Durham NC - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
2100 Erwin Rd, Durham 27705
Durham Office
1 Duke Medical Ctr, Durham 27710
(919) 684-8111 (Phone), (919) 681-8679 (Fax)
Duke Medical Center Hematology
201 Trent Dr STE MC3422, Durham 27710
(919) 684-5350 (Phone)
Duke University Medical Center
Ste 2C STE 3422, Durham 27710
(919) 684-5350 (Phone)
Durham Office
1 Duke Medical Ctr, Durham 27710
(919) 684-8111 (Phone), (919) 681-8679 (Fax)
Duke Medical Center Hematology
201 Trent Dr STE MC3422, Durham 27710
(919) 684-5350 (Phone)
Duke University Medical Center
Ste 2C STE 3422, Durham 27710
(919) 684-5350 (Phone)
Certifications:
Hematology, 2012, Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
2100 Erwin Rd, Durham 27705
Durham Office
1 Duke Medical Ctr, Durham 27710
Duke Medical Center Hematology
201 Trent Dr STE MC3422, Durham 27710
Duke University Medical Center
Ste 2C STE 3422, Durham 27710
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Office
1 Duke Medical Ctr, Durham 27710
Duke Medical Center Hematology
201 Trent Dr STE MC3422, Durham 27710
Duke University Medical Center
Ste 2C STE 3422, Durham 27710
Duke University Hospital
2301 Erwin Rd, Durham 27710
Education:
Medical School
In Univ Sch Of Med
Graduated: 1985
Duke University Hospital
In Univ Sch Of Med
Graduated: 1985
Duke University Hospital
Thomas Ortel, Durham NC
Specialties:
Hematologist
Address:
4117 N Roxboro St, Durham, NC 27704
Education:
Indiana University, School of Medicine - Doctor of Medicine
Indiana University-Purdue University (Indianapolis) - Doctor of Philosophy
Duke University Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
Indiana University-Purdue University (Indianapolis) - Doctor of Philosophy
Duke University Hospital - Fellowship - Hematology and Oncology (Internal Medicine)
Duke University Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)
Thomas L Ortel, Durham NC
Specialties:
Internal Medicine, Hematology, Hematology
Work:
Private Diagnostic Clinic
1000 Trent Dr, Durham, NC 27710
1000 Trent Dr, Durham, NC 27710
Education:
Indiana University(1985)
Method For Predicting An Increased Likelihood Of Antiphospholipid Syndrome In A Patient
US Patent:
2003010, Jun 5, 2003
Filed:
Jun 28, 2002
Appl. No.:
10/185186
Inventors:
Thomas Ortel - Durham NC, US
Zuowei Su - Durham NC, US
Paul Braun - Durham NC, US
Liliana Tejidor - Raleigh NC, US
Zuowei Su - Durham NC, US
Paul Braun - Durham NC, US
Liliana Tejidor - Raleigh NC, US
International Classification:
G01N033/53
US Classification:
435/007900
Abstract:
A method for predicting that an individual has antiphospholipid syndrome or an increased likelihood of having antiphospholipid syndrome, includes: a) providing a test sample from an individual; b) combining the test sample with phospholipids; c) directing a light beam at the test sample and monitoring light scattering or transmittance over time so as to provide a time-dependent measurement profile; d) determining if a value or a slope at or over a particular time in the time-dependent measurement profile is beyond a corresponding predetermined value or slope threshold; and if the value or slope in the time-dependent measurement profile is beyond the predetermined threshold, then determining that the individual has antiphospholipid syndrome or an increased risk of antiphospholipid syndrome. The phospholipids can be provided as part of a coagulation reagent, or as part of a reagent where coagulation is not activated. Confirmatory assays for particular antibodies to phospholipid binding proteins can be performed.
Chimeric Blood Coagulation Proteins
US Patent:
5587310, Dec 24, 1996
Filed:
Jul 11, 1994
Appl. No.:
8/273362
Inventors:
William H. Kane - Durham NC
Thomas L. Ortel - Durham NC
Thomas L. Ortel - Durham NC
Assignee:
Duke University - Durham NC
International Classification:
C07K 14745, C07K 14755, C12N 510, C12N 1512
US Classification:
4352402
Abstract:
Chimeric blood coagulation proteins are disclosed. The proteins are (i) coagulation factor V in which at least one A3, C1 or C2 domain exon thereof is replaced with the homologous exon of coagulation factor VIII; or (ii) coagulation factor VIII in which at least one A3, C1 or C2 domain exon thereof is replaced with the homologous exon of coagulation factor V. The chimeric proteins are useful for diagnostic purposes in epitope mapping and for therapeutic purposes in facilitating blood coagulations in patients in need of such treatment.